Prosecution Insights
Last updated: April 19, 2026
Application No. 17/504,826

SYSTEMS AND METHODS FOR ONSITE SORBENT MATERIAL REUSE

Non-Final OA §103
Filed
Oct 19, 2021
Examiner
BASS, DIRK R
Art Unit
1779
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BAXTER HEALTHCARE SA
OA Round
7 (Non-Final)
62%
Grant Probability
Moderate
7-8
OA Rounds
3y 9m
To Grant
84%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allow Rate
515 granted / 831 resolved
-3.0% vs TC avg
Strong +22% interview lift
Without
With
+22.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
32 currently pending
Career history
863
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
48.6%
+8.6% vs TC avg
§102
29.0%
-11.0% vs TC avg
§112
15.9%
-24.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 831 resolved cases

Office Action

§103
DETAILED ACTION Applicant’s request for continued examination filed March 12, 2026 is acknowledged. Claim 24 is amended, claims 1-23 and 31-35 are withdrawn, and claims 45-46 are canceled. Claims 24-25, 28-29, and 40-44 are further considered on the merits. Response to Amendment In light of applicant’s amendment, the examiner modifies the grounds of rejection set forth in the office action filed December 9, 2025. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 24-25, 28-29, and 40-44 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gerber et al., US 2015/0367052 (Gerber) in view of Thompson, US 6878283 (Thompson, of record) and Labib et al., US 2016/0375188 (Labib). Regarding claim 24, Gerber discloses a sorbent cartridge (abstract, figs. 12-13) comprising: A housing (REF 272, see “cartridge”, ¶ 0071) sized and shaped to accept multiple sorbent cartridge casings (see “sorbent pouches”, ¶ 0129) in a desired order, the housing comprising an exit end including an outlet and an inlet end including an inlet (see “fluid is directed through”, ¶ 0092 and “dialysate flows through the sorbent cartridge”, ¶ 0133); A first zirconium casing including H+ZP (see “zirconium phosphate”, ¶ 0028, 0107, 0120 and “multiple sorbent pouches”, ¶ 0118-0119) located within the housing; A second zirconium casing including Na+ZP (see “zirconium phosphate”, ¶ 0028, 0107, 0120 and “multiple sorbent pouches”, ¶ 0118-0119) located within the housing; At least one additional casing located within the housing such as a urease casing (¶ 0028, 0107); Wherein each of the first and second zirconium casing includes a refurbished zirconium compound (¶ 0121); and Wherein each casing includes a seal that seals to another one of the casings or to the housing when the housing is closed for treatment, such that fluid travelling through the housing during treatment is prevented from leaking between the casings and between the housing and the casings (¶ 0095); Wherein the first zirconium casing and the second zirconium casing are configured to be refurbished by flowing a refurbishment fluid through the housing in a reverse flow direction from the outlet to the inlet (via inlet/outlet of cartridge housing). Gerber does not disclose the housing exit end being closed and the inlet end comprising a removable cap threadedly connected to said inlet end. However, Thompson discloses dialysate sorbent cartridges (abstract, figs. 1-6) having a closed exit end (REF 400, fig. 5) and an inlet end comprising a removable cap (REF 450). At the time of invention, it would have been obvious to one having ordinary skill in the art to modify the cartridge of Gerber to utilize the cartridge end caps described in Thompson in order to prevent leakage and maintain sufficient fluid pressure during dialysate regeneration. While Gerber (in view of Thompson) discloses a removable cap (via “physical latch”, Thompson C5/L21-31), Gerber does not disclose the cap being connected via a threaded engagement. However, Labib discloses that it is common for dialysis cartridges to have removable caps secured to a housing by a variety of attachment methods including a threaded seal (¶ 0144). At the time of invention, it would have been obvious to one having ordinary skill in the art to modify the cartridge of Gerber (in view of Thompson) to have a threadedly connected cap as described in Labib since the examiner notes the equivalence of latches and threads for their use in the dialysis art and the selection of any of these known equivalents to removably secure a cap would be within the level of ordinary skill in the art (MPEP 2144.06). Lastly, while Gerber discloses using multiple zirconium phosphate casings containing both H+ and Na+, Gerber does not disclose the two separate casings containing different zirconium containing materials such as one casing containing H+ZP and another casing containing Na+ZP. However, Thompson discloses that it is common to include multiple different zirconium containing materials within dialysis sorbent cartridges (C6/L36-42). At the time of invention, it would have been obvious to one having ordinary skill in the art to modify the cartridge of Gerber to have different zirconium containing materials as described in Thompson since it has been shown that broadly providing multiple different zirconium containing materials within dialysis sorbent cartridges is effective in dialysis treatment and the selection of any of these known materials to include in said cartridge would a matter of obvious design choice absent a showing of criticality or unexpected results (MPEP 2144.07). Regarding claim 25, Gerber (in view of Thompson and Labib) discloses a sorbent cartridge wherein the housing is conically sized and shaped to accept multiple sorbent cartridge casings in a desired order and orientation (¶ 0110). Regarding claim 28, Gerber (in view of Thompson and Labib) discloses a sorbent cartridge where the zirconium casings are located in parallel within the housing (¶ 0131). Regarding claim 29, Gerber (in view of Thompson and Labib) discloses a sorbent cartridge wherein the zirconium casings are located in series within the housing (¶ 0127). Regarding claim 40, Gerber (in view of Thompson and Labib) discloses a sorbent cartridge wherein the at least one additional casing comprises an anion exchange resin casing (¶ 0008), a mechanical filter casing (¶ 0009), an activated carbon and filter casing (¶ 0008), and a urease casing (¶ 0008). Regarding claim 41, Gerber (in view of Thompson and Labib) discloses a sorbent cartridge comprising an additional activated carbon and filter casing (¶ 0008, 0118-0119). Regarding claims 42-43, while Gerber (in view of Thompson and Labib) does not disclose the recited order of casings, Gerber recognizes that the individual casings may be arranged in any preferred order (¶ 0119). Therefore, it would have been obvious to one having ordinary skill in the art at the time the invention was made to provide the recited order of casings since it has been held that rearranging parts of an invention involves only routine skill in the art absent a showing of criticality or unexpected results (MPEP 2144.04, Section VI, Part C). Regarding claim 44, Gerber (in view of Thompson and Labib) discloses a sorbent cartridge wherein the casings have a conical shape (¶ 0015, 0110). Response to Arguments Applicant’s arguments with respect to the rejection(s) of claim(s) 24 under 35 U.S.C. 103 have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of Thompson and Labib as seen above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DIRK R BASS whose telephone number is (571)270-7370. The examiner can normally be reached 8-4:30 EST Monday-Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Bobby Ramdhanie can be reached on (571) 270-3240. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. DIRK R. BASS Primary Examiner Art Unit 1779 /DIRK R BASS/Primary Examiner, Art Unit 1779
Read full office action

Prosecution Timeline

Oct 19, 2021
Application Filed
Oct 25, 2023
Non-Final Rejection — §103
Jan 29, 2024
Response Filed
Mar 21, 2024
Final Rejection — §103
Jun 17, 2024
Response after Non-Final Action
Jul 17, 2024
Request for Continued Examination
Jul 18, 2024
Response after Non-Final Action
Jul 26, 2024
Response Filed
Aug 02, 2024
Non-Final Rejection — §103
Oct 31, 2024
Response Filed
Jan 28, 2025
Final Rejection — §103
Feb 28, 2025
Response after Non-Final Action
Jul 31, 2025
Request for Continued Examination
Aug 01, 2025
Response after Non-Final Action
Aug 04, 2025
Non-Final Rejection — §103
Sep 17, 2025
Response Filed
Dec 05, 2025
Final Rejection — §103
Feb 10, 2026
Applicant Interview (Telephonic)
Feb 10, 2026
Examiner Interview Summary
Feb 23, 2026
Response after Non-Final Action
Mar 12, 2026
Request for Continued Examination
Mar 17, 2026
Response after Non-Final Action
Mar 24, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599667
METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS
2y 5m to grant Granted Apr 14, 2026
Patent 12594528
SPACER FILM WITH INTEGRATED LAMINATION STRIP
2y 5m to grant Granted Apr 07, 2026
Patent 12590955
METHODS AND SYSTEMS FOR PROCESSING PARTICLES
2y 5m to grant Granted Mar 31, 2026
Patent 12588779
DRIP COFFEE FILTER STRUCTURE
2y 5m to grant Granted Mar 31, 2026
Patent 12582496
Manifold For A Medical/Surgical Waste Collection Assembly
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

7-8
Expected OA Rounds
62%
Grant Probability
84%
With Interview (+22.4%)
3y 9m
Median Time to Grant
High
PTA Risk
Based on 831 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month